VIVUS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch VIVUS and buy or sell other stocks, ETFs, and their options commission-free!

About VVUS

VIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity, diabetes, sleep apnea and sexual health. The listed name for VVUS is VIVUS, Inc. 

CEO
John P. Amos
CEOJohn P. Amos
Employees
Employees
Headquarters
Campbell, California
HeadquartersCampbell, California
Founded
1991
Founded1991
Employees
Employees

VVUS Key Statistics

Market cap
2.10M
Market cap2.10M
Price-Earnings ratio
-0.04
Price-Earnings ratio-0.04
Dividend yield
Dividend yield
Average volume
174.43K
Average volume174.43K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$4.55
52 Week high$4.55
52 Week low
$0.0654
52 Week low$0.0654

Stock Snapshot

As of today, VIVUS(VVUS) shares are valued at $0.47. The company's market cap stands at 2.1M, with a P/E ratio of -0.04.

On 2026-03-02, VIVUS(VVUS) stock opened at —, reached a high of —, and a low of —.

The VIVUS(VVUS)'s current trading volume is 0, compared to an average daily volume of 174.43K.

During the past year, VIVUS(VVUS) stock moved between $0.07 at its lowest and $4.55 at its peak.

During the past year, VIVUS(VVUS) stock moved between $0.07 at its lowest and $4.55 at its peak.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.